Navigation Links
Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC's Drug Discovery & Development of Innovative Therapeutics Conference
Date:6/30/2008

WESTBOROUGH, Mass. June 30 /PRNewswire/ -- Joseph B. Bolen, Ph.D., CSO of Millennium Pharmaceuticals, will chair the Focus on Cancer track IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics Conference and Exhibition taking place August 4-7 at the World Trade Center Boston & Seaport Hotel in Boston, MA. The cancer track presentations will focus on therapies for Hematology, Lung Cancer, Blood Borne Cancers, and Clinical Biomarkers.

Bolen has confirmed academia speakers including: Kenneth C. Anderson, M.D., Dana Farber Cancer Institute, Harvard Medical School; Bruce E. Johnson, M.D., Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital; Mark A. Israel, M.D., Dartmouth Medical School; Neal Rosen, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center; Massimo Loda, M.D., Dana Farber Cancer Institute, Brigham & Women's Hospital, Harvard Medical School

Companies also giving technical conference presentations in this cancer track include Alnylam Pharmaceuticals, Amgen, Inc., ARIAD Pharmaceuticals Inc., ArQule, Inc., AstraZeneca R&D Boston, Bristol-Myers Squibb Company, Exelixis Inc, Genzyme Corporation, Infinity Pharmaceuticals, Inc, Merck Research Laboratories, Novartis Institutes for BioMedical Research, OncoMed Pharmaceuticals Inc, The Johnson & Johnson Family of Companies.

Additional conference sessions at Drug Discovery & Development of Innovative Therapeutics conference include:

-- Cardio-Metabolic Disease Drug Discovery and Development

-- Translational Medicine/Research

-- Transforming Technologies

-- Anti-Infective Drug Discovery and Development

-- Neurodegenerative Disease Drug Discovery and Development

-- Inflammation in Drug Discovery and Development

-- Orphan Diseases: Fast-Tracking Orphan Drugs and Scientific Advances -- The Next Generation of Therapeutics: Emerging Biologics, Stem Cells and RNAi

IBC's Drug Discovery & Devel
'/>"/>

SOURCE IBC Life Sciences
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
2. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
3. SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors
4. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
5. J. Craig Venter Institute Names Robert Friedman, Ph.D., Deputy Director of West Coast Facility
6. Barry Ginsberg, M.D., Ph.D. Elected to Biodels Board of Directors
7. DermTech Names Herbert A. Fritsche, Ph.D., Chief of Clinical Chemistry at M.D. Anderson Cancer Center to Companys Scientific Advisory Board
8. Takedas Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO
9. Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors
10. Adnavance Technologies Inc. Appoints Christian P. Valcke, Ph.D., to Its Scientific Advisory Board
11. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire-FirstCall/--CellThe...llpresentatthe21stAnnualPiperJaffrayHealthCareConf...heNewYorkPalaceHotel. ,, CTIwillpresentonTuesda...r).AliveaudiowebcastofCTI,spresentationwillbeavail...ailableforreplayafterwards. , ,PiperJaffrayHealth...
(Date:11/23/2009)...HAMPAIGN, Ill. You can think of it as origami ve...sity of Illinois have developed a technique for fa...licon structures from thin films by coupling photo...apillary interactions. , The films, only a few mi...not possible with thicker pieces of the same mater...
(Date:11/23/2009)...raphene consists of a two-dimensional carbon layer...onal lattice, resembling a honeycomb. Carbon nanot...iles of graphene sheets form graphite. Graphene bo...emely tear-resistant, an excellent thermal conduct...rittleness and ductility. In addition, graphene is...
(Date:11/23/2009)..., MISSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-Y...cesproductdevelopmentcompanythatidentifiesandadvan...ctsatvariousstagesofdevelopment,todayreportedthatC...rialevaluatingCYT387,apotent,orally-administeredJA...nicinRochester,Minnesota.AproposaltomergeCytopiain...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
...ring of outstanding convertible debentures of Vict...t , , QUEBEC, April 30 /PRNewswire-FirstCall/ - V...d Otto Bock HealthCare GmbH ("Otto Bock") announce...ership agreement to establish a joint venture to d...developed by Victhom,s Neurobionix division. , The...
... April 30 /PRNewswire-Asia-FirstCall/ -- China-Bio... Company"), a leading Chinese firm,specializing in... and,distribution of probiotics products ( http://... Company,s management will present at the upcoming...lations in New York on May 18,2009. , The date...
...RNewswire-FirstCall/ - Oncolytics Biotech Inc. (TS...2009 Annual and Special Meeting of the Shareholder.... (MT) at the Telus World of Science, 701-11 Stree... the meeting, Dr. Brad Thompson, President and CEO...veloping REOLYSIN(R) as a potential cancer therape...
Other Biology Technology:Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 2Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 3Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 5China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 2China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 3Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting 2
(Date:11/23/2009)... biomedical engineer and cardiologist Tzung "John"...ans distinguish cardiac emergencies requiring imme...h drugs and lifestyle change. , Angiograms, imag...eding the heart, offer an inside view of the inter...n revealing deposits of a dangerous fatty substanc...
(Date:11/23/2009)...edical Sciences (NIGMS), part of the National Inst... for grants in scientific areas it identified as "...ant program to stimulate biomedical research and t...covery and Reinvestment Act (Recovery Act). , "T...significant impact on a field of biomedical scienc...
(Date:11/23/2009)...tor of the Interuniversity Professorship in Law an...niversity of the Basque Country. The Professorship...experts such as researchers in the fields of molec...ics. , The Interuniversity Professorship in Law ...o and the Basque Country was created in 1993. The ...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2For Chest Pain in the ER CT Angiography May Be Best 61756 1Artemisinin Resistance Threatens Efforts to Control Malaria 61752 1Artemisinin Resistance Threatens Efforts to Control Malaria 61752 2Artemisinin Resistance Threatens Efforts to Control Malaria 61752 3Artemisinin Resistance Threatens Efforts to Control Malaria 61752 4U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61748 1U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61748 2
...nal water sports could all be adversely affected i...coming years prove true, according to research pub...ls . , Scientists from Biotechnology and Biologic...Wyke Research have found for the first time that t...on the amount of phosphorus lost from the soil int...
...Envisat and the Italian Space Agency,s COSMO-SkyMe... Earth during and after the 6.3 earthquake that sh... on 6 April 2009. , Scientists from Italy,s Istit...ente (IREA-CNR) and the Istituto Nazionale di Geof... Aperture Radar (SAR) data from these satellites t...
...director of the Frances and Joseph Weinberg Unit f...ciences at Thomas Jefferson University was recentl...dation grant to identify why drug therapies that s...S) mouse models have proven unsuccessful in human ...eam will closely examine critical aspects of drug ...
Other Biology News:Changing climate will lead to devastating loss of phosphorus from soil 2Satellites show how Earth moved during Italy quake 2Jefferson researcher awarded Landenberger Foundation grant for ALS research 2
...ue Arrays are intended for laboratory research use...al buffered formalin and embedded in paraffin. Ti... certified pathologists. Tissue cores were remove...new recipient paraffin block, in an array pattern,...
...ue Arrays are intended for laboratory research use...al buffered formalin and embedded in paraffin. Ti... certified pathologists. Tissue cores were remove...new recipient paraffin block, in an array pattern,...
...n rat tissue extracts (liver, kidney, spleen, and ... was also tested with microsomal fractions prepare...simple and reliable method for measuring NDPase ac...ction of the inorganic phosphate released from NDP...
CNS Side Effect Profile (CNS SEP) from Novascreen-a Caliper Life Sciences Company
Biology Products: